| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst, New South Wales, Australia; 2 Viertel Centre for Research in Cancer Control, Queensland Cancer Fund, Brisbane, Queensland, Australia; 3 Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, Victoria, Australia; 4 University of York, York, United Kingdom; 5 School of Public Health, University of Sydney; and 6 St. Vincent's Hospital, Sydney, New South Wales, Australia
Requests for reprints: Claire M. Vajdic, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Level 2/376 Victoria Street, Darlinghurst, New South Wales 2010, Australia. Phone: 61-2-9385-0900; Fax: 61-2-9385-0920. E-mail: cvajdic{at}nchecr.unsw.edu.au
Infections were examined as possible risk factors for non-Hodgkin lymphoma in a population-based case-control study in New South Wales and the Australian Capital Territory, Australia. Incident cases (n = 694) had no history of HIV infection or transplantation. Controls (n = 694) were randomly selected from electoral rolls and frequency matched to cases by age, sex, and area of residence. A postal questionnaire and telephone interview measured history of specific infections, occupational exposures, and behavioral and other risk factors for infection. Blood samples were tested for antibodies to human T-lymphotrophic virus type I and hepatitis C virus. Logistic regression models included the three matching variables and ethnicity. There was no association between risk of non-Hodgkin lymphoma and any of the variables analyzed, including sexually transmitted infections, sexual behavior, blood transfusions, influenza, acne, and either occupational or domestic exposure to zoonotic infections. Non-Hodgkin lymphoma risk was nonsignificantly elevated (odds ratio, 2.99; 95% confidence interval, 0.78-11.51) for those with a history of injecting drug use. Three cases and two controls (odds ratio, 1.32; 95% confidence interval, 0.22-7.98) tested positive to hepatitis C virus infection and none tested positive to human T-lymphotrophic virus type I/II infection. This study provides consistent evidence that sexually transmitted infections and zoonoses are not risk factors for non-Hodgkin lymphoma. (Cancer Epidemiol Biomarkers Prev 2006;15(6):11028)
This article has been cited by other articles:
![]() |
K. E. Smedby, H. Hjalgrim, E. T. Chang, K. Rostgaard, B. Glimelius, H.-O. Adami, and M. Melbye Childhood Social Environment and Risk of Non Hodgkin Lymphoma in Adults Cancer Res., November 15, 2007; 67(22): 11074 - 11082. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Wang, W. Cozen, J. R. Cerhan, J. S. Colt, L. M. Morton, E. A. Engels, S. Davis, R. K. Severson, N. Rothman, S. J. Chanock, et al. Immune Mechanisms in Non-Hodgkin Lymphoma: Joint Effects of the TNF G308A and IL10 T3575A Polymorphisms with Non-Hodgkin Lymphoma Risk Factors Cancer Res., May 15, 2007; 67(10): 5042 - 5054. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Dal Maso and S. Franceschi Hepatitis C Virus and Risk of Lymphoma and Other Lymphoid Neoplasms: A Meta-analysis of Epidemiologic Studies. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2078 - 2085. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |